Will FDA require EA microarray proficiency tests? | GenomeWeb

Expression Analysis is preparing to begin a second round of its proficiency testing program for microarray facilities, in which it compares variability in Affymetrix gene expression experiment outcomes within and among different labs.

But while experts agree that standardization will be important to the industry, whether or not the US Food and Drug Administration will require proficiency testing as a basis for approving diagnostic products remains a big question.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.